The Second Affiliated Hospital of Zhejiang University School of Medicine (SAHZU)
Welcome,         Profile    Billing    Logout  
 0 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yan, Xiaobo
NCT03932071: Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma

Recruiting
4
150
RoW
Zoledronic Acid
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lung Metastases, Tumor Necrosis
01/20
01/23
NCT05607940: Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery

Not yet recruiting
2/3
260
NA
blood volume loss based blood transfusion, hemoglobin concentration based blood transfusion
Second Affiliated Hospital, School of Medicine, Zhejiang University
Blood Transfusion
06/25
12/25
BOMB, NCT04158843: Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis

Recruiting
N/A
183
RoW
Radical resection, Radical radiotherapy, Palliative treatment
xuexin he
Breast Cancer, Oligometastasis
12/22
12/26
He, Xuexin
FAVOR, NCT04337658: Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast Cancer

Not yet recruiting
3
493
RoW
Pertuzumab, Perjeta, Trastuzumab, Herceptin, Fulvestrant, Faslodex, Capecitabine, Xeloda
Second Affiliated Hospital, School of Medicine, Zhejiang University
HER2-positive Breast Cancer
04/24
04/26
SHERO, NCT04158856: Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer

Not yet recruiting
2
60
NA
Pyrotinib, Pyrotinib Maleate Tablets, Trastuzumab, Herceptin
xuexin he
HER2-positive Breast Cancer
05/23
05/30
HER2BAT, NCT04158947: A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone

Recruiting
2
130
RoW
Afatinib, BIBW 2992, T-DM1, Trastuzumab emtansine
xuexin he
HER2-positive Breast Cancer, Brain Metastases
12/23
03/24
NCT04760431: TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN)

Not yet recruiting
2
120
RoW
Trastuzumab, Herceptin, Taxanes, Docetaxel, Paclitaxel, Paclitaxel (Albumin bound), Paclitaxel Liposome, Pertuzumab, Perjeta, Tyrosine kinase inhibitor, Pyrotinib, Neratinib, Tucatinib
Second Affiliated Hospital, School of Medicine, Zhejiang University, Peking University International Hospital, Sun Yat-sen University, Zhejiang University
HER2-positive Breast Cancer, Brain Metastases
09/24
09/25

Download Options